Phaseline

Targets › TOPI

TOPI: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Oncology.

Open in Phaseline: the race on TOPI, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Grupo Espanol Multidisciplinario del Cancer DigestivoLIFEPEARLS-Irinotecan
Chemoembolization with irinotecan-loaded hydrogel microspheres for intra-arterial hepatic
TOPIPhase 2Colorectal Cancer Metastatic–

Conditions

Colorectal Cancer Metastatic (1)

Modalities

mixed (1)

Companies

Grupo Espanol Multidisciplinario del Cancer Digestivo (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.